title: Sirolimus-tacrolimus combination immunosuppression.
abstract: A series of 32 recipients of liver, kidney, or pancreas transplants who were treated with sirolimus and low-dose tacrolimus experienced a low rate of rejection and excellent graft function without drug-related toxic effects.
authors.forename: V C
authors.initials: VC
authors.lastname: McAlister
authors.forename: Z
authors.initials: Z
authors.lastname: Gao
authors.forename: K
authors.initials: K
authors.lastname: Peltekian
authors.forename: J
authors.initials: J
authors.lastname: Domingues
authors.forename: K
authors.initials: K
authors.lastname: Mahalati
authors.forename: A S
authors.initials: AS
authors.lastname: MacDonald
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D016030:Kidney Transplantation / Q000276:immunology; D016031:Liver Transplantation / Q000276:immunology; D008297:Male; D008875:Middle Aged; D016035:Pancreas Transplantation / Q000276:immunology; D020123:Sirolimus / Q000008:administration & dosage*; D016559:Tacrolimus / Q000008:administration & dosage*
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus; D016559:Tacrolimus